Prime Medicine’s (PRME) “Buy” Rating Reaffirmed at HC Wainwright
Prime Medicine (NYSE:PRME – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They presently have a $10.00 price objective on the stock. HC Wainwright’s target price indicates a potential upside of 354.55% from the stock’s current price. Several other brokerages have […]
Prime Medicine (NYSE:PRME – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They presently have a $10.00 price objective on the stock. HC Wainwright’s target price indicates a potential upside of 354.55% from the stock’s current price. Several other brokerages have […]
